Additional Information for Cardioplegic Solution
Cardioplegic solutions are a type of medication used during cardiac surgery to temporarily stop the heart's activity. These solutions are typically administered through the coronary arteries to induce cardiac arrest, allowing surgeons to perform procedures on a still heart.
Cardioplegic solutions are part of the supply class Drugs And Biologicals in the supply group Medical, Dental, And Veterinary Equipment And Supplies. They are specifically designed for use in medical settings, particularly in cardiac surgery units.
These solutions are formulated to provide a combination of electrolytes, buffers, and other substances that help protect the heart muscle during the period of cardiac arrest. They work by reducing the heart's oxygen demand and preventing damage to the heart tissue during surgery.
Cardioplegic solutions are available in different formulations, including crystalloid and blood-based solutions. Crystalloid solutions contain electrolytes, such as potassium, magnesium, and calcium, while blood-based solutions may also include red blood cells or other blood components.
The choice of cardioplegic solution depends on various factors, including the patient's condition, the type of surgery being performed, and the surgeon's preference. The specific formulation and administration method will be determined by the medical team based on the individual patient's needs.
It's important to note that cardioplegic solutions should only be used under the supervision of trained medical professionals in a clinical setting. They are not intended for self-administration or use outside of a medical procedure.
If you have any further questions or need more information, feel free to ask.
Related Item Names for INC 38536 Cardioplegic Solution
NATO Stock Numbers with Item Name 38536 Cardioplegic Solution Page 1 of 1
- PLEGISOL
- RNCC: 5 | RNVC: 1 | DAC: 4